NDAC
This article was originally published in The Tan Sheet
Executive Summary
Committee will meet jointly with Pharmaceutical Science Advisory Committee's Drug Safety & Risk Management Subcommittee April 22, according to tentative advisory committee meeting dates posted on FDA's Web site Feb. 28. Although no agenda has been formally announced, acetaminophen and liver toxicity could be topic for discussion (1"The Tan Sheet" Feb. 18, 2002, p. 3). Additional NDAC meeting dates are April 23, June 21...
You may also be interested in...
Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.